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Aspirin triggers the biosynthesis of oxygenated metabolites from arachidonic, eicosapentaenoic, and doco-
sahexaenoic (DHA) acids. In a preceding issue, Serhan et al. (2011) describe a novel aspirin-triggered DHA
pathway for the biosynthesis of a potent anti-inflammatory and proresolving molecule.Arachidonic (AA), eicosapentaenoic (EPA),
and docosahexaenoic (DHA) acids are
essential fatty acids (EFAs) that are re-
quired in human diet to supplement their
endogenous production in humans. All
three are characterized by being poly-
unsaturated with 4-6 nonconjugated cis
double bonds and are generally identified
either as omega-6 or omega-3 (Figure 1).
These fatty acids are enzymatically re-
leased upon demand from their mem-
brane-associatedphospholipidprecursors
and serve as substrates for a number of
key enzymes to produce a wide array of
oxidative products that play major roles in
regulating the immune function. The
omega-3s DHA and EPA are enriched
within the cell membranes of brain, ret-
ina, and testis where they are believed
to have a protective role (Simopoulos,
1999). There is diverse and significant evi-
dence that Western diets are deficient in
these omega-3s, and this deficiency has
been linked with many disease states. For
this reason, they are widely supplemented
in human diet with products based on
marine oils and certain plants.
It is now well recognized that uncon-
trolled inflammation is associated with
many diseases that are very prominent
inWestern populations, including arthritis,
cardiovascular and respiratory diseases,
as well as neurodegenerative conditions
such as Alzheimer’s and multiple scle-
rosis. Charles Serhan and his collabora-
tors have identified potent oxidative prod-
ucts of DHA that he named resolvins,
protectins, and maresins. These auta-
coids are locally synthesized in inflamma-
tory exudates and were shown to have
antiinflammatory and proresolving prop-
erties (Serhan et al., 2000, 2002). They
are also produced in neural and brain
tissues after injury (Serhan et al., 2000,
2002). Over the past decade, Serhan and
coworkers have been able to structurally1208 Chemistry & Biology 18, October 28, 20characterize these new products by com-
bining careful synthetic chemistry struc-
tural analysis with insightful biological
experiments.
A key feature associated with the
discovery of the novel DHA oxidative
metabolites is the role of aspirin in the
biosynthesis of these molecules. Aspirin,
the first chemically produced medication
was synthesized in the 1850s and con-
tinues to be widely used for its analgesic
and antiinflammatory properties. How-
ever, aspirin has also served as an invalu-
able pharmacological probe for unravel-
ing several aspects of the inflammatory
syndrome. First, during the 1970s, John
Vane demonstrated that aspirin attenu-
ates the biosynthesis of prostaglandins
(Vane, 1982) by acting as an inhibitor of
the enzyme cyclooxygenase-1 (COX-1).
This discovery served as a basis for the
development of a number of the widely
used nonsteroidal antiinflammatory drugs
(NSAIDs). In parallel, Samuelsson and
coworkers identified a potent platelet-
activating product biosynthesized from
arachidonic acid. They named it throm-
boxane A2 and showed that its production
is also inhibited by aspirin (Samuelsson,
1982).
The pioneering work of Samuelsson
and Vane led to the identification of
several families of oxygenated products
from arachidonic acid, represented by
the prostaglandins, leukotrienes throm-
boxanes and lipoxins. Prostaglandins
(PGs) and leukotrienes (LTs) are generally
considered as pro-inflammatory where
they participate in the first line of defense
within the cell while lipoxins (LXs) serve as
antiinflammatory mediators promoting re-
solution. Limiting the endogenous pro-
duction of PGs and LTs has served as
a basis for the development of antiinflam-
matory medications. The most successful
of these, including aspirin, have targeted11 ª2011 Elsevier Ltd All rights reservedthe enzyme cyclooxygenase-1 whose in-
hibition results in decreased levels of
prostaglandins and thromboxanes.
A new aspect for aspirin’s role in the
biosynthesis of oxidative lipid modulators
was recognized with the identification
of the second eicosanoid oxidative en-
zyme cyclooxygenase-2 (COX 2), which
is found abundantly in the vascular endo-
thelium. It was shown that aspirin acts on
this enzyme by acetylating its catalytic
serine residue and prevents prostaglan-
din formation. However, although acety-
lated, the enzyme is still capable of other
catalytic action producing a new product
15R-HETE, which is, in turn, converted
by leukocytes to the potent antiinflamma-
tory aspirin-triggered 15-epi-lipoxin A4
which limits leukocyte entry into sites of
inflammation (Takano et al., 1997). This
finding followed the earlier observation
by Serhan and collaborators (Cla`ria and
Serhan, 1995) that aspirin triggered the
biosynthesis of novel lipid oxidative prod-
ucts identified as 15-epi-aspirin-triggered
lipoxins. This novel enzymatic function
for COX-2 is unique for this enzyme and
not shown by COX-1. Structural studies
attribute this enzymatic differentiation to
the observation that unlike COX-1, the
COX-2 catalytic domain is not entirely
blocked by its aspirin-induced acetylation
and is still capable of carrying out different
enzymatic functions. In a human trial set-
ting, Gilroy showed recently that aspirin
triggers formation of lipoxins and limits
the infiltration of leukocytes into the skin
(Morris et al., 2009).
In a recent Chemistry and Biology re-
port, Serhan and colleagues identified a
proresolvin pathway involving DHA (Ser-
han et al., 2011). This work describes the
chemical characterization of an aspirin-
triggered neuroprotectin D1, a dihydroxy
DHA product enzymatically produced
in murine systems by isolated human
Figure 1. Products of Oxidative Transformations of Polyunsaturated
Essential Fatty Acids
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turally related normal DHA
dihydroxylated product ob-
tained by the action of lipoxy-
genase on DHA, in which the
17-OH has the S-absolute
configuration, the new pro-
duct which is produced by
the aspirin-acetylated COX-2
enzyme has a 17R-OH con-
figuration (Figure 1). Com-
plete structural characteri-
zation was carried out by
elegant synthetic and analyt-
ical work as with the earlieridentified neuroprotectins (Marcheselli
et al., 2010). This newprotectin has potent
antiinflammatory actions and stimulates
resolution by activating macrophages
and assists in clearing sites of inflamma-
tion by stimulating macrophages to up-
take dead leukocytes and other cellular
debris.
The structural characterization of these
intriguing and very potent oxygenated
lipid molecules coupled with the careful
characterization of their immunomodulat-
ing properties opens the door for the
development of novel therapeutics in the
all-important field of inflammation. Char-
acterization of the protein targets forthese molecules is still at the early stages
while correlation between their structures
and activities is incomplete. Progress in
these fronts should provide the basis
for thoughtful target-based drug design
to produce more biochemically stable
and therapeutically targeted medications.
Serhan’s finding also suggests the com-
bined use of DHA and aspirin as an attrac-
tive therapeutic avenue for the treatment
of inflammatory conditions.REFERENCES
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The development of a method for the amplification of PNA tags (Svensen et al., in this issue of Chemistry &
Biology) should expand the range of biological targets amenable to screening using PNA-encoded combina-
torial libraries and thus facilitate the discovery of new biologically useful agents.The screening of libraries of molecules to
identify those with desirable biological
properties is fundamental to the drug
discovery process and chemical biology
studies in general. Solid-phase split-
and-mix combinatorial synthesis tech-
niques can rapidly generate libraries ofvast numbers of compounds suitable for
screening (Maclean et al., 1997; Harris
and Winssinger, 2005; Dı´az-Mocho´n
et al., 2005). However, such libraries are
obtained as complex mixtures, and deter-
mining the chemical identity of any indi-
vidual biologically active member presentis challenging. Toward this end, a number
of chemical-encoding strategies have
been developed where each molecule in
the library becomes associated with (or
incorporates) a unique tag encoding its
unique synthetic history and thus molec-
ular structure. This information can thener Ltd All rights reserved 1209
